Recombinant Human CYP46A1 Protein，GST

CYP46A1, or cytochrome P450 46A1, is a crucial enzyme primarily involved in the metabolism of cholesterol in the brain, where it catalyzes the conversion of cholesterol to 24S-hydroxycholesterol. This metabolic pathway plays a significant role in maintaining cholesterol homeostasis and influences various neurological functions and processes, including neuroprotection and synaptic plasticity. Dysregulation of CYP46A1 has been implicated in a variety of neurodegenerative disorders, such as Alzheimer's disease, where altered cholesterol metabolism contributes to the pathophysiology. Research on recombinant CYP46A1 allows for detailed studies on its enzymatic function, structure, and interactions with substrates and inhibitors. By producing this protein in a recombinant form, scientists can explore its biochemical characteristics and potential as a therapeutic target, aiming to restore cholesterol balance in the brain and mitigate the effects of neurodegenerative diseases. Moreover, understanding CYP46A1's role can provide insights into the broader implications of cholesterol metabolism in cognitive functions and neurological health, thereby paving the way for novel interventions in treating or preventing related disorders. This ongoing research highlights the enzyme's significance not just for basic neuroscience but also for developing strategies to combat cognitive decline and enhance brain resilience.